A Study to Evaluate the Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients
Tab Title Description
Describes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
- Rochester, Minnesota: 19-000181
NCT ID: NCT04041219
Sponsor Protocol Number: 19-000181
About this study
The primary purpose of this study is to demonstrate the feasibility of sublingual (SL) administration of tacrolimus in blood and marrow transplant (BMT) patients.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
- Individuals will be identified from within the adult allogeneic BMT program at Mayo Clinic in Rochester, Minnesota.
- Participants must be prescribed tacrolimus for treatment or prevention of GVHD.
- Vulnerable populations.
- Those lacking the capacity to consent in English.
- Those declining to participate in research will be excluded.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
|Mayo Clinic Location
Mayo Clinic principal investigator
Heather May, Pharm.D.
Closed for enrollment
Publications are currently not available